Login / Signup
Novel BCR-ABL1 tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia.
Sara Malik
Shahzeb Hassan
Ahmet Emre Eskazan
Published in:
Expert review of hematology (2021)
Keyphrases
</>
chronic myeloid leukemia
replacement therapy